Spots Global Cancer Trial Database for Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

Official Title: Prospective, Randomized, Blinded Comparison of Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Unilateral, Immediate Breast Reconstruction

Study ID: NCT03393117

Conditions

Breast Cancer

Interventions

Liposomal Bupivacaine

Bupivacaine

Patient-Controlled Analgesia Pump

Oral Narcotic

Study Description

Brief Summary: The purpose of this study is to determine the most effective way to control post-operative breast pain for patients undergoing a unilateral, immediate breast reconstruction.

Detailed Description: This is a randomized controlled study to compare the effectiveness of a breast nerve block performed with bupivacaine as compared to liposomal bupivacaine in providing postsurgical analgesia in patients undergoing unilateral abdominally-based breast reconstruction at time of mastectomy. OBJECTIVES 1. Compare the amount of postoperative narcotic use in patients receiving a bupivacaine or liposomal bupivacaine pectoralis and serratus anterior nerve block. Compare these groups to a retrospective control cohort who received local anesthetic infusion but did not receive any nerve block. 2. Examine the incidence of narcotic-related side effects in the experimental groups by documenting incidents of nausea and vomiting, time to first ambulation, liquid and solid oral intake. 3. Survey patient satisfaction with pain management using a visual analog scale during their hospital stay.